Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Summaries of EU Legislation

Illicit drug trafficking — List of psychoactive substances

SUMMARY OF:

Decision 1999/615/JHA on 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties

Decision 2002/188/JHA on control measures and criminal sanctions in respect of the new synthetic drug PMMA

Decision 2003/847/JHA on control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2

Decision 2008/206/JHA on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions

Decision 2010/759/EU on submitting 4-methylmethcathinone (mephedrone) to control measures

Implementing Decision (EU) 2015/1873 on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures

Implementing Decision (EU) 2015/1874 on subjecting 4-methylamphetamine to control measures

Implementing Decision (EU) 2015/1875 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures

Implementing Decision (EU) 2015/1876 on subjecting 5-(2-aminopropyl)indole to control measures

Implementing Decision (EU) 2016/1070 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures

Implementing Decision (EU) 2017/369 on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures

Implementing Decision (EU) 2017/1774 on subjecting N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) to control measures

Implementing Decision (EU) 2017/2170 on subjecting N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures

Implementing Decision (EU) 2018/747 on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures

Implementing Decision (EU) 2018/748 on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures

Implementing Decision (EU) 2018/1463 on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures

WHAT IS THE AIM OF THE DECISIONS?

They aim to establish control measures and criminal penalties against the trafficking of new psychoactive substances (NPS)1.

KEY POINTS

The list of NPS includes:

  1. Methylthioamphetamine or 4-Methylthioamphetamine, as referred to in Council Decision 1999/615/JHA.
  2. Paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane, as referred to in Council Decision 2002/188/JHA.
  3. 2,5-dimethoxy-4-iodophenethylamine, 2,5-dimethoxy-4-ethylthiophenethylamine, 2,5-dimethoxy-4-(n)-propylthiophenethylamine and 2,4,5-trimethoxyamphetamine, as referred to in Council Decision 2003/847/JHA.
  4. 1-benzylpiperazine or 1-benzyl-1,4-diazacyclohexane or N-benzylpiperazine or benzylpiperazine, as referred to in Council Decision 2008/206/JHA.
  5. 4-methylmethcathinone, as referred to in Council Decision 2010/759/EU.
  6. 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45), as referred to in Council Implementing Decision (EU) 2015/1873.
  7. 4-methylamphetamine, as referred to in Council Implementing Decision (EU) 2015/1874.
  8. 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), as referred to in Council Implementing Decision (EU) 2015/1875.
  9. 5-(2-aminopropyl)indole, as referred to in Council Implementing Decision (EU) 2015/1876.
  10. 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP), as referred to in Council Implementing Decision (EU) 2016/1070.
  11. Methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA), as referred to in Council Implementing Decision (EU) 2017/369.
  12. N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), as referred to in Council Implementing Decision (EU) 2017/1774.
  13. N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), as referred to in Council Implementing Decision (EU) 2017/2170.
  14. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), as referred to in Council Implementing Decision (EU) 2018/747.
  15. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), as referred to in Council Implementing Decision (EU) 2018/748.

  16. N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), as referred to in Council Implementing Decision (EU) 2018/1463.

  17. 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), as referred to in Council Implementing Decision (EU) 2018/1463.

The European Commission can add further NPS to the list by means of a delegated act.

FROM WHEN DO THE DECISIONS APPLY?

Decisions have applied since:

Council Decision 2002/188/JHA
Council Decision 2003/847/JHA
Council Decision 2008/206/JHA
Council Decision 2010/759/EU
Council Implementing Decision (EU) 2015/1873
Council Implementing Decision (EU) 2015/1874
Council Implementing Decision (EU) 2015/1875
Council Implementing Decision (EU) 2015/1876
Council Implementing Decision (EU) 2016/1070
Council Implementing Decision (EU) 2017/369
Council Implementing Decision (EU) 2017/1774
Council Implementing Decision (EU) 2017/2170
Council Implementing Decision (EU) 2018/747
Council Implementing Decision (EU) 2018/748
Council Implementing Decision (EU) 2018/1463

BACKGROUND

The EU Drugs Strategy 2013-2020 is put into action through two consecutive four-year Action Plans.

For further information see:

KEY TERMS

  1. New psychoactive substance: a substance in pure form or in a preparation that is not covered by the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol, or by the 1971 United Nations Convention on Psychotropic Substances but may pose health or social risks similar to those posed by the substances covered by those Conventions.

MAIN DOCUMENTS

Council Decision 1999/615/JHA of defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties (OJ L 244, , p. 1)

Council Decision 2002/188/JHA of concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA (OJ L 63, , p. 14)

Council Decision 2003/847/JHA of concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2 (OJ L 321, , pp. 64-65)

Council Decision 2008/206/JHA of on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions (OJ L 63, , pp. 45-46)

Council Decision 2010/759/EU of on submitting 4-methylmethcathinone (mephedrone) to control measures (OJ L 322, , pp. 44-45)

Council Implementing Decision (EU) 2015/1873 of on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures (OJ L 275, , pp. 32-34)

Council Implementing Decision (EU) 2015/1874 of on subjecting 4-methylamphetamine to control measures (OJ L 275, , pp. 35-37)

Council Implementing Decision (EU) 2015/1875 of on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures (OJ L 275, , pp. 38-42)

Council Implementing Decision (EU) 2015/1876 of on subjecting 5-(2-aminopropyl)indole to control measures (OJ L 275, , pp. 43-45)

Council Implementing Decision (EU) 2016/1070 of on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures (OJ L 178, , pp. 18-20)

Council Implementing Decision (EU) 2017/369 of on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures (OJ L 56, , pp. 210-212)

Council Implementing Decision (EU) 2017/1774 of on subjecting N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) to control measures (OJ L 251, , pp. 21-22)

Council Implementing Decision (EU) 2017/2170 of on subjecting N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures (OJ L 306, , pp. 19-20)

Council Implementing Decision (EU) 2018/747 of on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures (OJ L 125, , pp. 8-9)

Council Implementing Decision (EU) 2018/748 of on subjecting the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures (OJ L 125, , p.p 10-11)

Council Implementing Decision (EU) 2018/1463 of on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures (OJ L 245, , pp. 9-11)

last update

Top